These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27917384)

  • 61. Classification of Intervertebral Disc Disease.
    Fenn J; Olby NJ;
    Front Vet Sci; 2020; 7():579025. PubMed ID: 33134360
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The chondrodystrophic dog: A clinically relevant intermediate-sized animal model for the study of intervertebral disc-associated spinal pain.
    Thompson K; Moore S; Tang S; Wiet M; Purmessur D
    JOR Spine; 2018 Mar; 1(1):e1011. PubMed ID: 29984354
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Variants of ACAN are associated with severity of lumbar disc herniation in patients with chronic low back pain.
    Perera RS; Dissanayake PH; Senarath U; Wijayaratne LS; Karunanayake AL; Dissanayake VHW
    PLoS One; 2017; 12(7):e0181580. PubMed ID: 28742099
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration.
    Wu Y; Shen S; Shi Y; Tian N; Zhou Y; Zhang X
    Front Bioeng Biotechnol; 2022; 10():823945. PubMed ID: 35309994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 3D assessment of intervertebral disc degeneration in zebrafish identifies changes in bone density that prime disc disease.
    Kague E; Turci F; Newman E; Yang Y; Brown KR; Aglan MS; Otaify GA; Temtamy SA; Ruiz-Perez VL; Cross S; Royall CP; Witten PE; Hammond CL
    Bone Res; 2021 Aug; 9(1):39. PubMed ID: 34465741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mesenchymal Stem Cell-Derived Exosomes as a Novel Strategy for the Treatment of Intervertebral Disc Degeneration.
    Lu L; Xu A; Gao F; Tian C; Wang H; Zhang J; Xie Y; Liu P; Liu S; Yang C; Ye Z; Wu X
    Front Cell Dev Biol; 2021; 9():770510. PubMed ID: 35141231
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SIRT1 Inhibits the Catabolic Effect of IL-1β Through TLR2/SIRT1/NF-κB Pathway in Human Degenerative Nucleus Pulposus Cells.
    Shen J; Fang J; Hao J; Zhong X; Wang D; Ren H; Hu Z
    Pain Physician; 2016 Jan; 19(1):E215-26. PubMed ID: 26752489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preclinical in vivo animal models of intervertebral disc degeneration. Part 1: A systematic review.
    Poletto DL; Crowley JD; Tanglay O; Walsh WR; Pelletier MH
    JOR Spine; 2023 Mar; 6(1):e1234. PubMed ID: 36994459
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduced expression of insulin-like growth factor 1 receptor leads to accelerated intervertebral disc degeneration in mice.
    Li B; Zheng XF; Ni BB; Yang YH; Jiang SD; Lu H; Jiang LS
    Int J Immunopathol Pharmacol; 2013; 26(2):337-47. PubMed ID: 23755749
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The genetics of intervertebral disc degeneration. Associated genes.
    Kalichman L; Hunter DJ
    Joint Bone Spine; 2008 Jul; 75(4):388-96. PubMed ID: 18485784
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Wogonin mitigates intervertebral disc degeneration through the Nrf2/ARE and MAPK signaling pathways.
    Fang W; Zhou X; Wang J; Xu L; Zhou L; Yu W; Tao Y; Zhu J; Hu B; Liang C; Li F; Hua J; Chen Q
    Int Immunopharmacol; 2018 Dec; 65():539-549. PubMed ID: 30412851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. TGF-β1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model.
    Zhang J; Li Z; Chen F; Liu H; Wang H; Li X; Liu X; Wang J; Zheng Z
    Exp Mol Med; 2017 Sep; 49(9):e379. PubMed ID: 28935976
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review.
    Ohnishi T; Iwasaki N; Sudo H
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159202
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Lin Y; Tang G; Jiao Y; Yuan Y; Zheng Y; Chen Y; Xiao J; Li C; Chen Z; Cao P
    Oxid Med Cell Longev; 2018; 2018():3692752. PubMed ID: 30210652
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-κB pathway in rats.
    Wu X; Liu Y; Guo X; Zhou W; Wang L; Shi J; Tao Y; Zhu M; Geng D; Yang H; Mao H
    Cell Death Dis; 2018 Jan; 9(2):98. PubMed ID: 29367664
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives.
    Liu W; Ma Z; Wang Y; Yang J
    Bioact Mater; 2023 May; 23():274-299. PubMed ID: 36439088
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Zheng Y; Lin Y; Chen Z; Jiao Y; Yuan Y; Li C; Xu X; Cao P
    Int J Clin Exp Pathol; 2018; 11(7):3445-3453. PubMed ID: 31949722
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Yiqi Huoxue Recipe Delayed Intervertebral Disc Degeneration by Activating Autophagy.
    Dai F; Yu P; Yu Z; Jiang H; Ma Z; Liu J
    Front Pharmacol; 2021; 12():705747. PubMed ID: 34483910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biological Behavior of Human Nucleus Pulposus Mesenchymal Stem Cells in Response to Changes in the Acidic Environment During Intervertebral Disc Degeneration.
    Liu J; Tao H; Wang H; Dong F; Zhang R; Li J; Ge P; Song P; Zhang H; Xu P; Liu X; Shen C
    Stem Cells Dev; 2017 Jun; 26(12):901-911. PubMed ID: 28298159
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Matrix metalloproteinase-3 and vitamin d receptor genetic polymorphisms, and their interactions with occupational exposure in lumbar disc degeneration.
    Yuan HY; Tang Y; Liang YX; Lei L; Xiao GB; Wang S; Xia ZL
    J Occup Health; 2010; 52(1):23-30. PubMed ID: 20009418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.